Cochrane Review Group
Pregnancy and Childbirth
252 systematic reviews in Pregnancy and Childbirth ask 3,601 questions. 20.2% have no studies to answer them, 23% rest on very low certainty evidence and 17.6% reach moderate or high certainty.
Reviews
252
Questions
3,601
current versions
No studies
20.2%
Moderate or high
17.6%
No studies 726 · 20.2%Ungraded 421 · 11.7%Very low 828 · 23%Low 993 · 27.6%Moderate 486 · 13.5%High 147 · 4.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Magnesium sulphate vs placebo (outcomes Major neurodevelopmental disability (school age)** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | RR 0.92 [0.53, 1.62] | 2 studies · 940 participants | Very low |
Magnesium sulphate vs placebo (outcomes Breastfeeding at hospital discharge** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulphate vs placebo (outcomes Women’s views of treatment** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Midwife continuity models vs other models of care Third or fourth degree tear · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.1 [0.81, 1.49] | 7 studies · 9437 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Maternal readmission within 28 days · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.52 [0.78, 2.96] | 1 study · 1195 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Attendance at birth by known midwife · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 9.13 [5.87, 14.21] | 11 studies · 9273 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Apgar score less than or equal to 7 at 5 minutes · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.95 [0.72, 1.24] | 13 studies · 12806 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Fetal loss before 24 weeks gestation · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.82 [0.67, 1.01] | 12 studies · 15913 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Regional analgesia (epidural/spinal) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.79, 0.92] | 15 studies · 17754 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Fetal loss at or after 24 weeks gestation · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.24 [0.73, 2.13] | 12 studies · 16122 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Neonatal death (baby born alive at any gestation and dies within 28 days) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.43, 1.71] | 10 studies · 14718 participants | Very low |
Summary of findings table ‐ Vitamin B12 supplementation vs placebo/no vitamin B12 supplementation Maternal anaemia · pregnant women Vitamin B12 supplementation during pregnancy for maternal and child health outcomes (2024) · Cochrane | RR 1.08 [0.93, 1.26] | 2 studies · 284 participants | Very low |
Reviews 252
Skin preparation for preventing infection following caesarean section
CochraneSoF table
12 questions
Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections
CochraneSoF table
4 questions
Acupuncture or acupressure for pain management during labour
CochraneSoF table
49 questions
Intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labour
CochraneSoF table
7 questions
Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage
CochraneSoF table
7 questions
Interventions for leg cramps in pregnancy
CochraneSoF table
17 questions
Complementary and alternative therapies for post‐caesarean pain
CochraneSoF table
80 questions
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants
CochraneSoF table
8 questions
Multi‐professional simulation‐based team training in obstetric emergencies for improving patient outcomes and trainees' performance
CochraneSoF table
7 questions
Interventions for preventing postpartum constipation
CochraneSoF table
17 questions
Aspirin (single dose) for perineal pain in the early postpartum period
CochraneSoF table
5 questions
Setting and techniques for monitoring blood pressure during pregnancy
CochraneSoF table
45 questions
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
CochraneSoF table
20 questions
Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies
CochraneSoF table
6 questions
Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well‐being
CochraneSoF table
14 questions
Anaesthesia/analgesia for manual removal of retained placenta
CochraneSoF table
7 questions
Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth
CochraneSoF table
9 questions
Mechanical and surgical interventions for treating primary postpartum haemorrhage
CochraneSoF table
64 questions
Support during pregnancy for women at increased risk of low birthweight babies
CochraneSoF table
10 questions
Antibiotics for asymptomatic bacteriuria in pregnancy
CochraneSoF table
3 questions
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
CochraneSoF table
21 questions
Medical treatment for early fetal death (less than 24 weeks)
CochraneSoF table
14 questions
Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes
CochraneSoF table
28 questions
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology
CochraneSoF table
3 questions
Antiplatelet agents for preventing pre‐eclampsia and its complications
CochraneSoF table
7 questions